Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2007; 32(2): 125-127


Dropridol and Metoclopramide in the Prevention of Postoperative Nausea and Vomiting

M.R. Afhami, P. Hasanzadeh Salmasi, J.Rahimiye Panahi.




Abstract

Objective: To asses the efficacy of droperidol and metoclopramide for prevention of post operative
nausea and vomiting (PONV) in patients undergoing ophthalmic surgery under general anesthesia.
Materials and Methods: This is a double blind, placebo controlled randomized study performed at
Tabriz University of Medical Sciences, Tabriz, Iran on one hundred and fifty ASA physical status 1 or 2
(classification of physical status by American Society of Anesthesiologists) adult patients undergoing
elective ophthalmic surgery (cataract). All the patients were anesthetized with endotracheal intubation and
received either metoclopramide 0.15mg/kg, droperidol 0.02mg/kg or placebo approximately 10-15
minutes before extubation. Direct observation of the vomiting by the nurse in the Post Anesthesia Care
Unit (PACU) for at least 2 hours and in the ward for 24 hours was made. Chi-square test with descriptive
statistical method was employed for data analysis.
Results: There significant difference between groups received pharmacological intervention and placebo
group (P

Key words: Vomiting, nausea, antiemetics, , droperidol, metoclopramide, post operative.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.